NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Mahindra & Mahindra's Earnings Fall Short of Expectations in Latest Quarter

Mahindra & Mahindra (M&M) reported an earnings before interest, taxes, depreciation, amortization, and merger (EBITDAM) of 14.1% in its latest quarter, which was slightly below the expectations of ICICI Securities. The research firm had anticipated a stronger performance from the auto sector, but M&M's farm earnings fell short of expectations. However, the impact of commodity inflation and an adverse mix was partially offset by higher operating leverage.

Key Figures:

SegmentActual EBITMExpected EBITMDifference
Auto13.8%13.5%0.3%
Farm12.5%13.5%-1%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

M&M's outlook for the auto segment remains positive, driven by its robust UV portfolio and recent launches. However, the company is expected to face challenges from rising commodity inflation. The research firm has retained a BUY rating for the company, with a stock price target of INR 4,000 based on a sum-of-the-parts (SoTP) valuation approach. This represents an upside of INR 50 from the current stock price of INR 3,950, implying a multiple of 24 times the company's core earnings per share (EPS) for fiscal year 2028.

In terms of volume growth, M&M has guided for mid-to-high teen growth in its utility vehicle (UV) segment for fiscal year 2027. However, the growth in the domestic tractor segment is expected to moderate due to a high base in the previous year. M&M has guided for mid-single-digit growth in this segment for fiscal year 2027.

Investor Takeaway

Investors should consider buying Mahindra and Mahindra due to its robust UV portfolio and recent launches.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.